Sleep apnoea is a common disorder that is estimated to affect approximately 4% of men and 2% of women in middle age1. Untreated, it can have serious consequences on personal wellbeing and lifestyle, affecting learning and memory, metabolism and weight, mood, safety, cardiovascular health and propensity to develop certain diseases.
Effective therapies are available, however. LISA® is Linde Healthcare’s leading programme for people with sleep disorders. With over 20 years’ experience in treating sleep apnoea, we have gained invaluable insights for delivering sleep and oxygen therapies to hundreds of thousands of homecare patients.
Multi-step programme with robust adherence support
LISA® stands for Leading Independent Sleep Aide. Delivered by qualified sleep specialists, LISA® combines a broad range of therapeutic devices and solutions with innovative, dedicated adherence support to help you meet your personal goals.
LISA® is like your very own personal sleep fitness trainer, designing an individualised therapy programme to reflect your needs. We also work hand in hand with physicians and payors in order to deliver an optimum therapy outcome for everyone.
1 Young T. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230-1235.